Cancer Therapeutics:from the laboratory to the clinic - BIOS8400

Looking for a different module?

Module delivery information

Location Term Level1 Credits (ECTS)2 Current Convenor3 2024 to 2025
Canterbury
Spring Term 7 15 (7.5) Michelle Garrett checkmark-circle

Overview

This module provides students with critical perspectives upon current and emerging cancer therapies, how they are developed, and how they are applied in the clinical setting. The harnessing of scientific knowledge in the treatment of disease requires a complex series of highly regulated studies that must be performed under highly regulated legal and ethical frameworks. This module reviews the transition from promising cancer therapy to fully realised therapeutic agent, using specific therapies as examples. It will also discuss the emerging potential for personalised medicine based on patient-specific molecular biomarkers.

Details

Contact hours

Total Contact Hours: 27
Total Private Study Hours: 123
Total Study Hours: 150

Method of assessment

Essay (1,000 words) – 50%
Report (2,000 words) – 50%

Indicative reading

Ritter, J.M. et al. (2019). Rang and Dale's Pharmacology, Nineth Edition. London: Elsevier

See the library reading list for this module (Canterbury)

Learning outcomes

The intended subject specific learning outcomes. On successfully completing the module students will be able to:
Demonstrate comprehensive understanding and critically evaluate current clinical management of cancer.
Demonstrate a critical appreciation of stages of pharmaceutical development in harnessing laboratory-based research through pre-clinical and in vivo evaluation and clinical trials.
Demonstrate a broad understanding of the industrial and regulatory processes that lead to the licensing of therapeutic drugs.
Demonstrate knowledge and understanding of the development of specific therapeutic agents and the complex processes that determine progression from the bench to the clinic, for instance small chemical entities and antibody conjugates.
Demonstrate cutting-edge understanding and knowledge of the complexity of personalisation of medicine in the "omics" era.

The intended generic learning outcomes. On successfully completing the module students will be able to:
Demonstrate the ability to organise information clearly, present information in a variety of forms, and adapt presentation for different audiences.
Interpret data accurately, marshalling information from published sources, and critically evaluate their own research and that of others.
Make use of constructive informal feedback from staff and peers and assess own progress to enhance performance and personal skills.
Demonstrate an ability to manage their time and workload efficiently to meet personal targets and imposed deadlines.
Demonstrate a professional ability to use appropriate technology to retrieve, analyse and present information.

Notes

  1. Credit level 7. Undergraduate or postgraduate masters level module.
  2. ECTS credits are recognised throughout the EU and allow you to transfer credit easily from one university to another.
  3. The named convenor is the convenor for the current academic session.
Back to top

University of Kent makes every effort to ensure that module information is accurate for the relevant academic session and to provide educational services as described. However, courses, services and other matters may be subject to change. Please read our full disclaimer.